A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone

doi:10.1200/JCO.2005.05.948

Back

A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Journal article

Peer reviewed

A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Michael N Neuss, Christopher E Desch, Kristen K McNiff, Peter D Eisenberg, Dean H Gesme, Joseph O Jacobson, Mohammad Jahanzeb, Jennifer J Padberg, John M Rainey, Jeff J Guo, …

Journal of clinical oncology, Vol.23(25), pp.6233-6239

2005-09-01

DOI: https://doi.org/10.1200/JCO.2005.05.948

PMID: 16087948

Abstract

Purpose The Quality Oncology Practice Initiative (QOPI) is a practice-based system of quality self-assessment sponsored by the participants and the American Society of Clinical Oncology (ASCO). The process of quality evaluation, development of the pilot questionnaire, and preliminary results are reported. Methods Physicians from seven oncology groups developed medical record abstraction measures based on practice guidelines and consensus-supported indicators of quality care. Each practice completed two rounds of records review and received practice and aggregate results. Mean frequencies of responses for each indicator were compared among practices. Results Participants universally, if informally, find QOPI helpful, and results show statistically significant variation among practices for several indicators, including assessing pain in patients close to death, documentation of informed consent for chemotherapy, and concordance with granulocytic and erythroid growth factor administration guidelines. Measures with universally high concordance include the use of serotonin antagonist antiemetics according to the ASCO guideline; the presence of a pathology report in the record; the use of chemotherapy flow sheets; and adherence to standard chemotherapy recommendations for patients with certain stages of breast, colon, and rectal cancer. Concordance with quality indicators significantly changed between survey rounds for several measures. Conclusion Pilot results indicate that the QOPI process provides a rapid and objective measurement of practice quality that allows comparisons among practices and over time. It also provides a mechanism for measuring concordance with published guidelines. Most importantly, it provides a tool for practice self-examination that can promote excellence in cancer care.

Metrics

4 Record Views

194 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.14 Nursing; 1.14.1115 Hospitalist
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative
Creators: Michael N Neuss - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Christopher E Desch - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Kristen K McNiff - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Peter D Eisenberg - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Dean H Gesme - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Joseph O Jacobson - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Mohammad Jahanzeb - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Jennifer J Padberg - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
John M Rainey - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Jeff J Guo - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Joseph V Simone - From Oncology Hematology Care, Cincinnati, OH; Virginia Cancer Institute, Richmond; American Society of Clinical Oncology, Alexandria; American Society for Therapeutic Radiology and Oncology, Fairfax, VA; California Cancer Care, Greenbrae, CA; Oncology Associates, Cedar Rapids, IA; N Shore Cancer Center, Peabody, MA; Boston Baskin Cancer Group, Memphis, TN; Louisiana Oncology Associates, Lafayette, LA; University of Cincinnati College of Pharmacy; Simone Consulting Company, Dunwoody, GA
Publication Details: Journal of clinical oncology, Vol.23(25), pp.6233-6239
Language: English
Resource Type: Journal article
PMID: 16087948
Record Identifier: 991031613093202976